LMB763

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMB763, covering 2019-11-26 to 2019-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH [Phase 2]